文献速递产科生殖医学母胎医学

黄体分泌产物与子痫前期

Secretory products of the corpus luteum and preeclampsia.
PubMed 文献 · Hum Reprod Update · 2021-01-01

本文为叙述性综述,检索PubMed/Medline至2020年6月,评估黄体分泌产物在健康妊娠中的作用及对冻融胚胎移植(FET)中子痫前期(PE)风险的影响。文章提出,程序化FET周期中缺乏功能性黄体可能导致类固醇激素、其代谢物及多肽失衡,影响蜕膜化、植入、血管生成和母体血流动力学,从而增加PE风险。

要点

  • 程序化FET周期中无功能性黄体,PE风险高于自然FET周期。
  • 黄体分泌孕酮、雌二醇、松弛素及血管活性/血管生成物质。
  • 孕酮和雌二醇代谢物具有血管生成特性,可能优化植入和胎盘形成。

核心结论

  • 黄体分泌产物对早期妊娠至关重要,其缺失或失衡可能增加程序化FET周期中子痫前期风险。

研究设计与样本

  • 叙述性综述,检索PubMed/Medline(更新至2020年6月)及相关文献,未采用正式的研究选择或评价标准。

主要发现

  • 程序化FET周期女性PE风险高于自然FET周期女性,可能与功能性黄体缺失有关。
  • 黄体分泌孕酮、雌二醇、松弛素及血管活性和血管生成物质,调节生殖功能。
  • 孕酮和雌二醇代谢物具有血管生成特性,可能优化植入和胎盘形成。
  • 无黄体孕妇血清松弛素几乎检测不到,可能影响母体心血管和肾脏对早期妊娠的适应。

临床怎么用

  • 认识程序化FET周期中黄体缺失对PE风险的影响,关注黄体分泌产物在早期妊娠中的作用。
  • 进一步理解黄体分泌产物可能有助于改善基于程序化FET周期的辅助生殖技术的疗效和安全性。

局限性

  • 本文为叙述性综述,未采用正式的研究选择或评价标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite significant advances in our understanding of the pathophysiology of preeclampsia (PE), there are still many unknowns and controversies in the field. Women undergoing frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium have been found to have an unexpected increased risk of PE compared to women who receive embryos in a natural FET cycle. The differences in risk have been hypothesized to be related to the absence or presence of a functioning corpus luteum (CL). OBJECTIVE AND RATIONALE: To evaluate the literature on secretory products of the CL that could be essential for a healthy pregnancy and could reduce the risk of PE in the setting of FET. SEARCH METHODS: For this review, pertinent studies were searched in PubMed/Medline (updated June 2020) using common keywords applied in the field of assisted reproductive technologies, CL physiology and preeclampsia. We also screened the complete list of references in recent publications in English (both animal and human studies) on the topics investigated. Given the design of this work as a narrative review, no formal criteria for study selection or appraisal were utilized. OUTCOMES: The CL is a major source of multiple factors regulating reproduction. Progesterone, estradiol, relaxin and vasoactive and angiogenic substances produced by the CL have important roles in regulating its functional lifespan and are also secreted into the circulation to act remotely during early stages of pregnancy. Beyond the known actions of progesterone and estradiol on the uterus in early pregnancy, their metabolites have angiogenic properties that may optimize implantation and placentation. Serum levels of relaxin are almost undetectable in pregnant women without a CL, which precludes some maternal cardiovascular and renal adaptations to early pregnancy. We suggest that an imbalance in steroid hormones and their metabolites and polypeptides influencing early physiologic processes such as decidualization, implantation, angiogenesis and maternal haemodynamics could contribute to the increased PE risk among women undergoing programmed FET cycles. WIDER IMPLICATIONS: A better understanding of the critical roles of the secretory products of the CL during early pregnancy holds the promise of improving the efficacy and safety of ART based on programmed FET cycles.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Pereira MM, Mainigi M, Strauss JF, et al. Secretory products of the corpus luteum and preeclampsia. Hum Reprod Update. 2021. PMID: 33748839. doi:10.1093/humupd/dmab003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。